The influence of parity and gravidity on first trimester markers of chromosomal abnormality

Prenatal Diagnosis

Volumn 20, Issue 10, 2000, Pages 792-794

  Spencer, K ^a   Ong, C Y T ^b   Liao, A W J ^b   Nicolaides, K H ^b  

^a HAROLD WOOD HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Chromosomal abnormality; Dawn syndrome; Free hCG; Nuchal translucency; PAPP A; Prenatal screening; Trisomy 21

Indexed keywords

BIOCHEMICAL MARKER; CHORIONIC GONADOTROPIN BETA SUBUNIT; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ADULT; ARTICLE; CHROMOSOME ABERRATION; DOWN SYNDROME; FEMALE; FIRST TRIMESTER PREGNANCY; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; NECK; PARITY; PREGNANCY; PREGNANCY COMPLICATION; PRENATAL SCREENING; PRIORITY JOURNAL; SCREENING TEST; STATISTICAL ANALYSIS; TRISOMY 21;

ADULT; BIOLOGICAL MARKERS; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; DOWN SYNDROME; FEMALE; GRAVIDITY; HUMANS; MASS SCREENING; MATERNAL AGE; PARITY; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PRENATAL DIAGNOSIS; ULTRASONOGRAPHY, PRENATAL;

EID: 0033745809     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0223(200010)20:10<792::AID-PD914>3.0.CO;2-5     Document Type: Article

References (19)

1. Calculation of Down's syndrome risk
2. Co-variables in first trimester maternal serum screening
3. Multiparity and Down's syndrome
4. Effect of parity on human chorionic gonadotrophin levels and Down's syndrome screening
5. Parity and Down syndrome
6. Down syndrome: Seasonality and parity effects
7. Decreased maternal serum hCG levels with increasing gravidity and parity
8. Refinements in managing maternal weight adjustment for prenatal screening results
9. Increased parity and risk of trisomy 21 - Review of 37 110 live births
10. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation
11. The influence of gravidity on Down's syndrome screening with free beta hCG
12. A rapid screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free β-hCG and PAPP-A
13. Screening for trisomy 13 by fetal nuchal translucency and maternal serum free beta hCG and PAPP-A at 10-14 weeks of gestation
14. Maternal serum free beta hCG and PAPP-A in fetal sex chromsome defects in the first trimester
15. Screening for triploidy by fetal nuchal translucency and maternal serum free β-hCG and PAPP-A at 10-14 weeks of gestation
16. OSCAR - One Stop Clinic for Assessment of Risk for fetal anomalies: A report of the first year of prospective screening for chromosomal anomalies in the first trimester
17. The influence of ethnic origin on first trimester biochemical markers of chromosomal abnormalities
18. Screening for trisomy 18 by fetal nuchal translucency and maternal serum free beta hCG and PAPP-A at 10-14 weeks of gestation
19. Serum markers for Down's syndrome in relation to number of previous births and maternal age